| abstract |
The present disclosure provides compositions and methods employing stem cell-derived cardiomyocytes. In some embodiments, methods of generating cardiomyocytes from stem cells (e.g., induced pluripotent stem cells (iPS cells or IPSCs) and embryonic stem cells) are provided. In some embodiments, uses of such cells for research, compound screening and analysis, and therapeutics are provided. |